Director James Caruso receives 40,000 VTAK options at $1.15 exercise price

robot
Abstract generation in progress

Catheter Precision, Inc. director James Joseph Caruso received a grant of 40,000 stock options (VTAK) with an exercise price of $1.15 per share. These options are set to expire on March 26, 2036, and will vest entirely on the 180-day anniversary of the grant date. This transaction was reported via an SEC Form 4 filing and represents a compensation-related award rather than an open-market purchase.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin